Question 1

How many shares of SLNO does CITADEL ADVISORS LLC own?

Accepted Answer

CITADEL ADVISORS LLC previously held 0 shares of SLNO (SOLENO THERAPEUTICS INC) before exiting the position in 2026-Q2.

Question 2

What is CITADEL ADVISORS LLC's SLNO position worth?

Accepted Answer

CITADEL ADVISORS LLC's SLNO position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is CITADEL ADVISORS LLC buying or selling SLNO?

Accepted Answer

In 2026-Q2, CITADEL ADVISORS LLC exited their SLNO position entirely (-100.0% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy SLNO?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in SLNO in 2023-Q3. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$53.01	0
2026-Q1	Increased	386,545	+25.2%	$12.9M	0.0%	$37.72	34
2025-Q4	Decreased	308,830	-31.4%	$14.3M	0.0%	$46.29	0
2025-Q3	Decreased	450,126	-70.1%	$30.4M	0.0%	$68.16	0
2025-Q2	Decreased	1.5M	-4.5%	$126.1M	0.0%	$83.25	0
2025-Q1	Increased	1.6M	+62.1%	$112.6M	0.0%	$71.99	43
2024-Q4	Increased	972,410	+4372.9%	$43.7M	0.0%	$45.30	47
2024-Q3	Increased	21,740	+167.5%	$1.1M	0.0%	$49.13	41
2024-Q2	New	8,127	-	$331,582	0.0%	$40.80	33
2023-Q4	Exited	0	-100.0%	$0	0.0%	$40.25	0
2023-Q3	New	40,625	-	$1.2M	0.0%	$29.51	35

SLNO11 quarters

SLNO
11 quarters